Mengjiao Shi

Shaanxi Key Laboratory Of Chemical Additives For Industry
Xi'an, 710021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Photocatalytic Semireduction of Propiolamides in Microheterogeneous Solutions via Alkyne Radical Anions.

Photocatalytic Semireduction of Propiolamides in Microheterogeneous Solutions via Alkyne Radical Anions.

Journal: Organic letters

Published: April 06, 2026

Asymmetric Electrophilic Amination of Calix[4]arene Amines: Rapid Assembly of Inherently Chiral Diamine Frameworks.

Asymmetric Electrophilic Amination of Calix[4]arene Amines: Rapid Assembly of Inherently Chiral Diamine Frameworks.

Journal: Organic letters

Published: November 17, 2025

Deciphering the rules of disulfidptosis: a genome-wide signature for identifying disulfidptosis-related genes and analyzing hepatocellular carcinoma chemotherapy sensitivities.

Deciphering the rules of disulfidptosis: a genome-wide signature for identifying disulfidptosis-related genes and analyzing hepatocellular carcinoma chemotherapy sensitivities.

Journal: Free radical biology & medicine

Published: July 24, 2025

The contrasting regulatory effects of valproic acid on ferroptosis and disulfidptosis in hepatocellular carcinoma.

The contrasting regulatory effects of valproic acid on ferroptosis and disulfidptosis in hepatocellular carcinoma.

Journal: Theranostics

Published: April 13, 2025

NRF1-Induced lncRNA DDX11-AS1 Contributes to the Progression of Hepatocellular Carcinoma via Activating CA9 Expression and the MEK/ERK Pathway.

NRF1-Induced lncRNA DDX11-AS1 Contributes to the Progression of Hepatocellular Carcinoma via Activating CA9 Expression and the MEK/ERK Pathway.

Journal: Journal of hepatocellular carcinoma

Published: January 09, 2025

The CNC-family transcription factor NRF3: A crucial therapeutic target for cancer treatment.

The CNC-family transcription factor NRF3: A crucial therapeutic target for cancer treatment.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 20, 2024

Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2-SLC7A11 Signaling Pathway.

Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2-SLC7A11 Signaling Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 11, 2024

Targeting Disulfidptosis with Potentially Bioactive Natural Products in Metabolic Cancer Therapy.

Targeting Disulfidptosis with Potentially Bioactive Natural Products in Metabolic Cancer Therapy.

Journal: Metabolites

Published: August 31, 2024

Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis.

Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis.

Journal: Cell death & disease

Published: July 31, 2024

Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway.

Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway.

Journal: Free radical biology & medicine

Published: July 13, 2024

Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.

Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.

Journal: Cell biology and toxicology

Published: June 26, 2024

Mechanical Force-Induced cGAS Activation in Carcinoma Cells Facilitates Splenocytes into Liver to Drive Metastasis.

Mechanical Force-Induced cGAS Activation in Carcinoma Cells Facilitates Splenocytes into Liver to Drive Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 30, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026